<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IMR</journal-id>
<journal-id journal-id-type="hwp">spimr</journal-id>
<journal-title>Journal of International Medical Research</journal-title>
<issn pub-type="ppub">0300-0605</issn>
<issn pub-type="epub">1473-2300</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300060513487625</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300060513487625</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>Angiotensin-converting enzyme</italic> insertion/deletion gene polymorphism and risk of intracranial aneurysm in a Chinese population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Liu</surname><given-names>Yi</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Peng</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Hu</surname><given-names>Xiao</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Hu</surname><given-names>Yu</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Sun</surname><given-names>Hao-Gen</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Ma</surname><given-names>Wei-Chao</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Qiao</surname><given-names>Fei</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>He</surname><given-names>Min</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>You</surname><given-names>Chao</given-names></name>
<xref ref-type="corresp" rid="corresp1-0300060513487625"/>
</contrib>
</contrib-group>
<aff id="aff1-0300060513487625">Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China</aff>
<author-notes>
<corresp id="corresp1-0300060513487625">Prof Chao You, Department of Neurosurgery, West China Hospital, Sichuan University, 37 Guo Xue Road, Chengdu 610041, Sichuan Province, China. Email: <email>chaoyou@live.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>4</issue>
<fpage>1079</fpage>
<lpage>1087</lpage>
<history>
<date date-type="received"><day>2</day><month>2</month><year>2013</year></date>
<date date-type="accepted"><day>10</day><month>2</month><year>2013</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="sec10-0300060513487625"><title>Objective</title>
<p>The relationship between <italic>angiotensin-converting enzyme (ACE)</italic> insertion/deletion (I/D) gene polymorphisms and intracranial aneurysm (IA) has been studied in Caucasian and Japanese populations. The present study aimed to investigate this association in a Chinese population.</p>
</sec>
<sec id="sec11-0300060513487625"><title>Methods</title>
<p>Patients with confirmed IA and age- and sex-matched control subjects without evidence of IA were enrolled. <italic>ACE</italic> I/D gene polymorphisms were analysed using polymerase chain reaction–restriction fragment length polymorphism.</p>
</sec>
<sec id="sec12-0300060513487625"><title>Results</title>
<p>A total of 220 patients with IA and 220 matched controls were enrolled. In the IA group, 64, 106 and 50 patients were of the II, ID and DD genotypes, respectively, compared with 44, 99 and 77 subjects in the control group. The <italic>ACE</italic> DD genotype and D allele frequencies were significantly lower in the IA group compared with the control group. There were no statistically significant differences in the site, shape, size and Fisher Grade of aneurysms between genotypes in patients with IA.</p>
</sec>
<sec id="sec13-0300060513487625"><title>Conclusion</title>
<p>The <italic>ACE</italic> DD genotype may be a protective factor for IA in a Chinese population.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Intracranial aneurysm</kwd>
<kwd>angiotensin-converting enzyme</kwd>
<kwd>gene polymorphism</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0300060513487625" sec-type="intro"><title>Introduction</title>
<p>Intracranial aneurysm (IA) occurs in ∼2% of the population worldwide, meaning that over 20 million people in China will experience an IA.<sup><xref ref-type="bibr" rid="bibr1-0300060513487625">1</xref></sup> It is ∼1.6-times more common in women than in men, and the majority of ruptured IAs is observed in people between the ages of 40 and 60 years.<sup><xref ref-type="bibr" rid="bibr2-0300060513487625">2</xref></sup> Rupture of an IA accounts for &gt;90% of subarachnoid haemorrhage (SAH) cases.<sup><xref ref-type="bibr" rid="bibr3-0300060513487625">3</xref></sup> Despite diagnostic and therapeutic advances, ∼50% of SAH cases are fatal and cause considerable disability in ∼30% of affected individuals.<sup><xref ref-type="bibr" rid="bibr4-0300060513487625">4</xref><xref ref-type="bibr" rid="bibr5-0300060513487625"/>–<xref ref-type="bibr" rid="bibr6-0300060513487625">6</xref></sup> IA is a complex disease with both environmental and genetic components,<sup><xref ref-type="bibr" rid="bibr7-0300060513487625">7</xref><xref ref-type="bibr" rid="bibr8-0300060513487625"/>–<xref ref-type="bibr" rid="bibr9-0300060513487625">9</xref></sup> the latter of which has prompted many studies on the genetic determinants of IA in the last 10 years.<sup><xref ref-type="bibr" rid="bibr7-0300060513487625">7</xref><xref ref-type="bibr" rid="bibr8-0300060513487625"/>–<xref ref-type="bibr" rid="bibr9-0300060513487625">9</xref></sup></p>
<p>The renin–angiotensin–aldosterone system (RAAS) is essential to cardiovascular haemodynamics and plays an important role in the development of hypertension and cerebrovascular disease.<sup><xref ref-type="bibr" rid="bibr10-0300060513487625">10</xref></sup> Angiotensin-converting enzyme (ACE) is an important circulating enzyme in the RAAS that catalyses the conversion of angiotensin I to angiotensin I, and the degradation of bradykinin.<sup><xref ref-type="bibr" rid="bibr10-0300060513487625">10</xref></sup> Plasma and tissue concentrations of ACE are determined by the <italic>ACE</italic> gene (chromosome 17q23).<sup><xref ref-type="bibr" rid="bibr10-0300060513487625">10</xref></sup> The <italic>ACE</italic> gene has a functional insertion/deletion (I/D) polymorphism of a 287 base pair (bp) Alu sequence within intron 16.<sup><xref ref-type="bibr" rid="bibr11-0300060513487625">11</xref></sup> <italic>ACE</italic> DD carriers have higher local levels of ACE than individuals with the ID and II genotypes.<sup><xref ref-type="bibr" rid="bibr11-0300060513487625">11</xref>,<xref ref-type="bibr" rid="bibr12-0300060513487625">12</xref></sup> These polymorphisms have, therefore, been extensively studied in several adult cardiovascular diseases including ischaemic stroke,<sup><xref ref-type="bibr" rid="bibr13-0300060513487625">13</xref></sup> coronary heart disease<sup><xref ref-type="bibr" rid="bibr14-0300060513487625">14</xref></sup> and intracerebral haemorrhage.<sup><xref ref-type="bibr" rid="bibr15-0300060513487625">15</xref><xref ref-type="bibr" rid="bibr16-0300060513487625"/><xref ref-type="bibr" rid="bibr17-0300060513487625"/><xref ref-type="bibr" rid="bibr18-0300060513487625"/><xref ref-type="bibr" rid="bibr19-0300060513487625"/>–<xref ref-type="bibr" rid="bibr20-0300060513487625">20</xref></sup></p>
<p>Until now, the relationship between <italic>ACE</italic> I/D polymorphisms and IA has only been studied in Caucasian populations and in a single study from Japan.<sup><xref ref-type="bibr" rid="bibr20-0300060513487625">20</xref><xref ref-type="bibr" rid="bibr21-0300060513487625"/><xref ref-type="bibr" rid="bibr22-0300060513487625"/><xref ref-type="bibr" rid="bibr23-0300060513487625"/>–<xref ref-type="bibr" rid="bibr24-0300060513487625">24</xref></sup> The aim of the present hospital-based, case–control study was to investigate the association between <italic>ACE</italic> I/D polymorphisms and the risk of IA in a Chinese population.</p>
</sec>
<sec id="sec2-0300060513487625" sec-type="methods"><title>Patients and methods</title>
<sec id="sec3-0300060513487625"><title>Study population</title>
<p>Peripheral blood specimens, demographic information and medical and family histories were obtained from sequentially ascertained, unrelated patients admitted to the West China Hospital of Sichuan University, Chengdu, China between July 2010 and June 2012. Aneurysms in cases were confirmed and classified by magnetic resonance imaging (MRI) or computed tomography (CT)<sup><xref ref-type="bibr" rid="bibr25-0300060513487625">25</xref></sup> and cerebral angiography. Age- and sex-matched control subjects met the following criteria: confirmation of the absence of IA by digital subtraction angiography, MR angiography, or three-dimensional CT angiography; no medical history of any vascular disease, including IA or SAH; no family history of IA or SAH in first-degree relatives; were from the same geographic region as the cases. Healthy control subjects were recruited from the Department of Neurosurgery, West China Hospital of Sichuan University where they were attending a clinic for routine examination.</p>
<p>The Ethical Committee of the West China Hospital of Sichuan University approved the study protocols, and all participants gave written informed consent according to the Declaration of Helsinki.</p>
</sec>
<sec id="sec4-0300060513487625"><title>DNA extraction and genotyping</title>
<p>Leucocyte DNA was extracted from 10 ml of venous blood, anticoagulated with 1.6 mg/ml ethylenediaminetetra-acetic acid using a commercially available kit (Wizard® Genomic DNA Purification Kit, Promega, Madison, WI, USA) and stored at 4℃ until analysis. <italic>ACE</italic> I/D gene polymorphisms were analysed using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). PCR was performed in a final volume of 100 µl containing 1 µg genomic DNA, 100 pmol of each primer, 3 mmol/l magnesium chloride, 50 mmol/l potassium chloride, 10 mmol/l Tris-HCl (pH 8.4) and 0.5 U of <italic>Taq</italic> polymerase (Perkin Elmer, Foster City, CA, USA). Based on the GenBank reference sequence, the following PCR primers were used: forward-5′-CTGGAGACCACTCCCATCCTTTCT-3′ and reverse-5′-GATGT GGCCATCACATTCGTCAGAT-3′. DNA was denatured at 94℃ for 5 min, followed by 30 cycles of denaturation at 94℃ for 1 min, annealing at 67℃ for 1 min and extension at 72℃ for 2 min, with a final extension step of 5 min at 72,℃ using an Applied Biosystems® GeneAmp® PCR System 9700 thermal cycler (Applied Biosystems, Foster City, CA, USA). PCR products (490-bp insertion and 190-bp deletion) were separated by 2% agarose gel electrophoresis, stained with ethidium bromide and viewed with ultraviolet light. <italic>β-actin</italic> was used as an internal control gene. To confirm the genotyping results, &gt; 10% of PCR-amplified DNA samples were randomly selected by computer and sent for DNA sequencing.</p>
</sec>
<sec id="sec5-0300060513487625"><title>Statistical analyses</title>
<p>All statistical analyses were carried out using SPSS® statistical software, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows®. Differences between continuous variables and between categorical variables were assessed by Student's <italic>t</italic>-test and Pearson’s Χ<sup>2</sup>-test, respectively. Pearson’s Χ<sup>2</sup>-test was also used to examine any differences in allelic and genotypic frequencies between different groups, and odds ratios (OR) and 95% confidence intervals (CI) were calculated. Two-sided <italic>P</italic>-values were used, with <italic>P</italic> &lt; 0.05 considered statistically significant. Genotype distribution and allele frequencies were compared to the Hardy–Weinberg equilibrium model using Pearson’s Χ<sup>2</sup>-test.</p>
</sec>
</sec>
<sec id="sec6-0300060513487625" sec-type="results"><title>Results</title>
<p>The study population consisted of 220 patients with IA and 220 matched control subjects. Demographic characteristics of patients with IA and controls are summarized in <xref ref-type="table" rid="table1-0300060513487625">Table 1</xref>. There was no statistically significant difference between groups with respect to age, sex, or prevalence of risk factors including hypertension, smoking and alcohol consumption. Clinical characteristics of aneurysms including location, site, shapes, sizes and Fisher Grade<sup><xref ref-type="bibr" rid="bibr25-0300060513487625">25</xref></sup> are shown in <xref ref-type="table" rid="table1-0300060513487625">Table 1</xref>.
<table-wrap id="table1-0300060513487625" position="float"><label>Table 1.</label><caption><p>Demographic and clinical characteristics of Chinese patients with intracranial aneurysm (IA), and age-and sex-matched control subjects.</p></caption>
<graphic alternate-form-of="table1-0300060513487625" xlink:href="10.1177_0300060513487625-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Characteristic</th>
<th>Patients with IA <italic>n</italic> = 220</th>
<th>Controls <italic>n</italic> = 220</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Sex</td>
</tr>
<tr>
<td> Male</td>
<td>95 (43.2)</td>
<td>103 (46.8)</td>
</tr>
<tr>
<td> Female</td>
<td>125 (56.8)</td>
<td>117 (53.2)</td>
</tr>
<tr>
<td> Age, years</td>
<td>47.4 ± 11.3</td>
<td>45.6 ± 10.7</td>
</tr>
<tr>
<td>Hypertension</td>
</tr>
<tr>
<td> Yes</td>
<td>82 (37.3)</td>
<td>75 (34.1)</td>
</tr>
<tr>
<td> No</td>
<td>138 (62.7)</td>
<td>145 (65.9)</td>
</tr>
<tr>
<td>Smoking</td>
</tr>
<tr>
<td> Ever</td>
<td>56 (25.5)</td>
<td>54 (24.5)</td>
</tr>
<tr>
<td> Never</td>
<td>164 (74.5)</td>
<td>166 (75.5)</td>
</tr>
<tr>
<td>Alcohol consumption</td>
</tr>
<tr>
<td> Ever</td>
<td>47 (21.4)</td>
<td>45 (20.5)</td>
</tr>
<tr>
<td> Never</td>
<td>173 (78.6)</td>
<td>175 (79.5)</td>
</tr>
<tr>
<td>Family history of IA</td>
</tr>
<tr>
<td> Yes</td>
<td>5 (2.3)</td>
</tr>
<tr>
<td> No</td>
<td>215 (97.7)</td>
</tr>
<tr>
<td>Site of aneurysm</td>
</tr>
<tr>
<td> ACA</td>
<td>98 (44.6)</td>
</tr>
<tr>
<td> ICA</td>
<td>76 (34.5)</td>
</tr>
<tr>
<td> MCA</td>
<td>46 (20.9)</td>
</tr>
<tr>
<td>Shape of aneurysm</td>
</tr>
<tr>
<td> Saccular</td>
<td>178 (80.9)</td>
</tr>
<tr>
<td> Fusiform</td>
<td>33 (15.0)</td>
</tr>
<tr>
<td> Dissecting</td>
<td>9 (4.1)</td>
</tr>
<tr>
<td>Size of aneurysm</td>
</tr>
<tr>
<td> Small, &lt;15 mm</td>
<td>155 (70.5)</td>
</tr>
<tr>
<td> Larger, 15 – 25 mm</td>
<td>56 (25.4)</td>
</tr>
<tr>
<td> Giant, &gt;25 mm</td>
<td>9 (4.1)</td>
</tr>
<tr>
<td>Fisher Grade<sup><xref ref-type="table-fn" rid="table-fn2-0300060513487625">a</xref></sup></td>
</tr>
<tr>
<td> 1</td>
<td>24 (10.9)</td>
</tr>
<tr>
<td> 2</td>
<td>101 (45.9)</td>
</tr>
<tr>
<td> 3</td>
<td>65 (29.6)</td>
</tr>
<tr>
<td> 4</td>
<td>30 (13.6)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300060513487625">
<p>Data presented as <italic>n</italic> (%) of patients or mean ± SD.</p></fn>
<fn id="table-fn2-0300060513487625"><label>a</label><p>Fisher Grade classifies the appearance of subarachnoid haemorrhage (SAH) on computed tomography scan: 1, no haemorrhage evident; 2, SAH &lt; 1-mm thick; 3, SAH &gt; 1-mm thick; 4, SAH of any thickness with intraventricular haemorrhage or parenchymal extension.<sup><xref ref-type="bibr" rid="bibr25-0300060513487625">25</xref></sup></p></fn>
<fn id="table-fn3-0300060513487625">
<p>There were no statistically significant differences (<italic>P</italic> ≥ 0.05) between study groups with respect to any demographic variable (determined by Student's <italic>t</italic> test for continuous variables and Pearson’s Χ<sup>2</sup>-test for categorical variables).</p></fn>
<fn id="table-fn4-0300060513487625">
<p>ACA, anterior cerebral artery; ICA, internal carotid artery; MCA, middle cerebral artery.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>The <italic>ACE</italic> genotypes of patients with IA and matched controls are presented in <xref ref-type="table" rid="table2-0300060513487625">Table 2</xref>. All individual single nucleotide polymorphisms (SNPs) were within the Hardy–Weinberg equilibrium model in both study groups. The <italic>ACE</italic> DD genotype (<italic>P</italic> = 0.003) and D allele frequencies (<italic>P</italic> = 0.002) were significantly less frequently found in patients with IA compared with controls (<xref ref-type="table" rid="table2-0300060513487625">Table 2</xref>). When stratified by the site, shape, size and Fisher Grade, no statistically significant differences between genotypes were observed in patients with IA (<xref ref-type="table" rid="table3-0300060513487625">Table 3</xref>).
<table-wrap id="table2-0300060513487625" position="float"><label>Table 2.</label><caption><p>Genotype frequencies of <italic>angiotensin-converting enzyme</italic> gene insertion/deletion (I/D) polymorphisms among Chinese patients with intracranial aneurysm (IA), and age- and sex-matched control subjects.</p></caption>
<graphic alternate-form-of="table2-0300060513487625" xlink:href="10.1177_0300060513487625-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Genotype</th>
<th>Patients with IA <italic>n</italic> = 220</th>
<th>Controls <italic>n</italic> = 220</th>
<th>OR (95% CI)</th>
<th>Statistical significance<sup><xref ref-type="table-fn" rid="table-fn6-0300060513487625">a</xref></sup></th>
</tr></thead>
<tbody align="left">
<tr>
<td>II</td>
<td>64 (29.1)</td>
<td>44 (20.0)</td>
<td>1.00 (Ref)</td>
</tr>
<tr>
<td>ID</td>
<td>106 (48.2)</td>
<td>99 (45.0)</td>
<td>0.74 (0.46, 1.18)</td>
<td>NS</td>
</tr>
<tr>
<td>DD</td>
<td>50 (22.7)</td>
<td>77 (35.0)</td>
<td>0.45 (0.26, 0.75)</td>
<td><italic>P</italic> = 0.003</td>
</tr>
<tr>
<td>I allele frequency</td>
<td>234 (53.2)</td>
<td>187 (42.5)</td>
<td>1.00 (Ref)</td>
</tr>
<tr>
<td>D allele frequency</td>
<td>206 (46.8)</td>
<td>253 (57.5)</td>
<td>0.65 (0.50, 0.85)</td>
<td><italic>P</italic> = 0.002</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0300060513487625">
<p>Data presented as <italic>n</italic> (%) of patients.</p></fn>
<fn id="table-fn6-0300060513487625"><label>a</label><p>Pearson’s Χ<sup>2</sup>-test.</p></fn>
<fn id="table-fn7-0300060513487625">
<p>OR, odds ratio; CI, confidence interval; NS, not statistically significant (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0300060513487625" position="float"><label>Table 3.</label><caption><p>Stratification analysis of <italic>angiotensin-converting enzyme</italic> gene insertion/deletion (I/D) genotype frequency in Chinese patients with intracranial aneurysm.</p></caption>
<graphic alternate-form-of="table3-0300060513487625" xlink:href="10.1177_0300060513487625-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">Variable</th>
<th colspan="2">II, <italic>n</italic> = 64</th>
<th colspan="2">ID, <italic>n</italic> = 106</th>
<th colspan="2">DD, <italic>n</italic> = 50</th>
</tr>
<tr><th>OR (95% CI)</th>
<th>OR (95% CI)</th>
<th>OR (95% CI)</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Site of aneurysm</td>
<td>1 (Ref)</td>
<td>1 (Ref)</td>
<td>1 (Ref)</td>
</tr>
<tr>
<td> ACA, <italic>n</italic> = 98</td>
<td>31 (31.6)</td>
<td>1.09 (0.67, 1.78)</td>
<td>43 (43.9)</td>
<td>0.91 (0.59, 1.40)</td>
<td>24 (24.5)</td>
<td>1.08 (0.63, 1.85)</td>
</tr>
<tr>
<td> ICA, <italic>n</italic> = 76</td>
<td>25 (32.9)</td>
<td>1.13 (0.66, 1.92)</td>
<td>35 (46.1)</td>
<td>0.96 (0.60, 1.52)</td>
<td>16 (21.0)</td>
<td>0.93 (0.50, 1.72)</td>
</tr>
<tr>
<td> MCA, <italic>n</italic> = 46</td>
<td>8 (17.4)</td>
<td>0.60 (0.27, 1.33)</td>
<td>28 (60.9)</td>
<td>1.26 (0.75, 2.13)</td>
<td>10 (21.7)</td>
<td>0.96 (0.45, 2.02)</td>
</tr>
<tr>
<td>Shape of aneurysm</td>
<td>1 (Ref)</td>
<td>1 (Ref)</td>
<td>1 (Ref)</td>
</tr>
<tr>
<td> Saccular, <italic>n</italic> = 178</td>
<td>51 (28.6)</td>
<td>0.98 (0.65, 1.50)</td>
<td>87 (48.9)</td>
<td>1.01 (0.72, 1.43)</td>
<td>40 (22.5)</td>
<td>0.99 (0.62, 1.57)</td>
</tr>
<tr>
<td> Fusiform, <italic>n</italic> = 33</td>
<td>10 (30.3)</td>
<td>1.04 (0.49, 2.23)</td>
<td>15 (45.5)</td>
<td>0.94 (0.49, 1.81)</td>
<td>8 (24.2)</td>
<td>1.07 (0.47, 2.45)</td>
</tr>
<tr>
<td> Dissecting, <italic>n</italic> = 9</td>
<td>3 (33.3)</td>
<td>1.15 (0.30, 4.36)</td>
<td>4 (44.4)</td>
<td>0.92 (0.28, 3.06)</td>
<td>2 (22.2)</td>
<td>0.98 (0.21, 4.67)</td>
</tr>
<tr>
<td>Size of aneurysm</td>
<td>1 (Ref)</td>
<td>1 (Ref)</td>
<td>1 (Ref)</td>
</tr>
<tr>
<td> Small, &lt;15 mm, <italic>n</italic> = 155</td>
<td>46 (29.7)</td>
<td>1.02 (0.66, 1.57)</td>
<td>74 (47.7)</td>
<td>0.99 (0.69, 1.42)</td>
<td>35 (22.6)</td>
<td>0.99 (0.62, 1.60)</td>
</tr>
<tr>
<td> Larger, 15–25 mm, <italic>n</italic> = 56</td>
<td>16 (28.6)</td>
<td>0.98 (0.53, 1.83)</td>
<td>27 (48.2)</td>
<td>1.00 (0.60, 1.67)</td>
<td>13 (23.2)</td>
<td>1.02 (0.52, 2.01)</td>
</tr>
<tr>
<td> Giant, &gt;25 mm, <italic>n</italic> = 9</td>
<td>2 (22.2)</td>
<td>0.76 (0.16, 3.63)</td>
<td>5 (55.6)</td>
<td>1.15 (0.38, 3.53)</td>
<td>2 (22.2)</td>
<td>0.98 (0.21, 4.67)</td>
</tr>
<tr>
<td>Fisher Grade<sup><xref ref-type="table-fn" rid="table-fn11-0300060513487625">a</xref></sup></td>
<td>1 (Ref)</td>
<td>1 (Ref)</td>
<td>1 (Ref)</td>
</tr>
<tr>
<td> 1, <italic>n</italic> = 24</td>
<td>7 (29.2)</td>
<td>1.00 (0.41, 2.43)</td>
<td>11 (45.8)</td>
<td>0.95 (0.45, 2.01)</td>
<td>6 (25.0)</td>
<td>1.10 (0.43, 2.83)</td>
</tr>
<tr>
<td> 2, <italic>n</italic> = 101</td>
<td>28(27.7)</td>
<td>0.95 (0.58, 1.58)</td>
<td>51 (50.5)</td>
<td>1.05 (0.70, 1.58)</td>
<td>22 (21.8)</td>
<td>0.96 (0.55, 1.67)</td>
</tr>
<tr>
<td> 3, <italic>n</italic> = 65</td>
<td>20 (30.8)</td>
<td>1.06 (0.60, 1.88)</td>
<td>30 (46.2)</td>
<td>0.96 (0.59, 1.57)</td>
<td>15 (23.1)</td>
<td>1.02 (0.54, 1.93)</td>
</tr>
<tr>
<td> 4, <italic>n</italic> = 30</td>
<td>9 (30.0)</td>
<td>1.03 (0.47, 2.28)</td>
<td>14 (46.7)</td>
<td>0.97 (0.49, 1.90)</td>
<td>7 (23.3)</td>
<td>1.03 (0.43, 2.47)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-0300060513487625">
<p>Data presented as <italic>n</italic> (%) of patients.</p></fn>
<fn id="table-fn9-0300060513487625">
<p>There were no statistically significant differences (<italic>P</italic> ≥ 0.05) between genotypes with respect to any clinical variable as determined by Pearson’s Χ<sup>2</sup>-test.</p></fn>
<fn id="table-fn10-0300060513487625">
<p>OR, odds ratio; CI, confidence interval; ACA, anterior cerebral artery; ICA, internal carotid artery; MCA, middle cerebral artery.</p></fn>
<fn id="table-fn11-0300060513487625"><label>a</label><p>Fisher Grade classifies the appearance of subarachnoid haemorrhage (SAH) on computed tomography scan: 1, no haemorrhage evident; 2, SAH &lt; 1-mm thick; 3, SAH &gt; 1-mm thick; 4, SAH of any thickness with intraventricular haemorrhage or parenchymal extension.<sup><xref ref-type="bibr" rid="bibr25-0300060513487625">25</xref></sup></p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec7-0300060513487625" sec-type="discussion"><title>Discussion</title>
<p>The relationship between <italic>ACE</italic> I/D polymorphisms and frequency of IA has previously been studied in Caucasian populations.<sup><xref ref-type="bibr" rid="bibr20-0300060513487625">20</xref><xref ref-type="bibr" rid="bibr21-0300060513487625"/><xref ref-type="bibr" rid="bibr22-0300060513487625"/>–<xref ref-type="bibr" rid="bibr23-0300060513487625">23</xref></sup> Takenaka et al.<sup><xref ref-type="bibr" rid="bibr24-0300060513487625">24</xref></sup> were the first to investigate the association between <italic>ACE</italic> I/D polymorphisms and IA, and found that the frequency of the DD genotype in patients with IA was significantly lower compared with control subjects. These results suggested that genetic heterogeneity of the <italic>ACE</italic> gene may be correlated with the aetiology of IA. Other studies, conducted in UK and Polish patient populations, have demonstrated that the <italic>ACE</italic> I allele is associated with an increased risk of ruptured IA and that the II genotype is a risk factor for aneurysmal SAH, respectively.<sup><xref ref-type="bibr" rid="bibr20-0300060513487625">20</xref>,<xref ref-type="bibr" rid="bibr23-0300060513487625">23</xref></sup> These reports are consistent with the results from the present study. Contrary to these findings, however, a US study in a Caucasian population failed to find any evidence of an association between the allelic or genotypic distribution of the <italic>ACE</italic> I/D polymorphism and IA.<sup><xref ref-type="bibr" rid="bibr22-0300060513487625">22</xref></sup></p>
<p>In the last decade, many studies have been conducted to investigate the genetic factors associated with IA. A genetic meta-analysis of eight genes and 13 polymorphisms in ∼20000 individuals showed that there was a likely genetic basis for sporadic IA.<sup><xref ref-type="bibr" rid="bibr21-0300060513487625">21</xref></sup> The evidence base was, however, small compared with other complex disorders.<sup><xref ref-type="bibr" rid="bibr21-0300060513487625">21</xref></sup> The <italic>interleukin (IL)-6</italic>-572GG genotype has been shown to be associated with a heightened risk of IA in a Chinese population,<sup><xref ref-type="bibr" rid="bibr26-0300060513487625">26</xref></sup> and this finding is consistent with other published reports in Chinese Han and Cantonese populations.<sup><xref ref-type="bibr" rid="bibr27-0300060513487625">27</xref>,<xref ref-type="bibr" rid="bibr28-0300060513487625">28</xref></sup> A region between introns 7 and 15 of the <italic>cyclin-dependent kinase inhibitor 2B antisense RNA-1 (CDKN2BAS)</italic> gene, carrying the rs1333040-T allele, has also been associated with an increased risk of IA in Japanese patients.<sup><xref ref-type="bibr" rid="bibr5-0300060513487625">5</xref></sup> Furthermore, there is evidence of an association between the development of aneurysms and a polymorphism at a genetic variant of endoglin, a glycoprotein expressed on the surface of human vascular endothelial cells, in Japanese patients with IA.<sup><xref ref-type="bibr" rid="bibr29-0300060513487625">29</xref></sup> In another Chinese case–control study, it was suggested that the <italic>IL-12A</italic> and <italic>IL-12B</italic> genes are both associated with a greater risk of developing an IA.<sup><xref ref-type="bibr" rid="bibr30-0300060513487625">30</xref></sup> An increased risk of IA in a Korean population has been associated with the rs2621215 SNP in intron 46 of the <italic>collagen, type I, alpha-2 (COL1A2)</italic> gene.<sup><xref ref-type="bibr" rid="bibr31-0300060513487625">31</xref></sup> The rs42524 polymorphism of <italic>COL1A2</italic> could also be a genetic risk factor for sporadic IA among individuals of Chinese Han ethnicity.<sup><xref ref-type="bibr" rid="bibr32-0300060513487625">32</xref></sup> Another study in a Chinese population suggested that susceptibility to IA may be affected by the <italic>miR-34b/c</italic> rs4938723CC and <italic>TP53</italic> Arg72-Pro polymorphisms.<sup><xref ref-type="bibr" rid="bibr33-0300060513487625">33</xref></sup> Polymorphisms of homocysteine metabolism are also possible risk factors for the development of IA.<sup><xref ref-type="bibr" rid="bibr34-0300060513487625">34</xref></sup> The endothelial nitric oxide synthase T-786C SNP may be a genetic marker that differentiates between small and large ruptured IA,<sup><xref ref-type="bibr" rid="bibr35-0300060513487625">35</xref></sup> although other studies failed to confirm this finding.<sup><xref ref-type="bibr" rid="bibr36-0300060513487625">36</xref>,<xref ref-type="bibr" rid="bibr37-0300060513487625">37</xref></sup> Finally, polymorphisms in the <italic>matrix metalloproteinase-9</italic> and the <italic>kallikrein</italic> gene cluster have been linked to the pathogenesis of IA.<sup><xref ref-type="bibr" rid="bibr38-0300060513487625">38</xref><xref ref-type="bibr" rid="bibr39-0300060513487625"/>–<xref ref-type="bibr" rid="bibr40-0300060513487625">40</xref></sup></p>
<p>Molecular mechanisms underlying the association between <italic>ACE</italic> I/D polymorphism and the risk of IA remain unclear. <italic>ACE</italic> DD carriers have higher local levels of ACE than those with the ID and II genotypes.<sup><xref ref-type="bibr" rid="bibr11-0300060513487625">11</xref>,<xref ref-type="bibr" rid="bibr12-0300060513487625">12</xref></sup> Several studies in different populations have found that <italic>ACE</italic> I/D polymorphisms are strongly associated with hypertension, which is a known risk factor for IA.<sup><xref ref-type="bibr" rid="bibr41-0300060513487625">41</xref><xref ref-type="bibr" rid="bibr42-0300060513487625"/><xref ref-type="bibr" rid="bibr43-0300060513487625"/>–<xref ref-type="bibr" rid="bibr44-0300060513487625">44</xref></sup><italic>ACE</italic> I/D polymorphisms have also been extensively studied in several cardiovascular adult diseases, such as thoracic aortic dissection,<sup><xref ref-type="bibr" rid="bibr45-0300060513487625">45</xref></sup> ischaemic stroke,<sup><xref ref-type="bibr" rid="bibr13-0300060513487625">13</xref></sup> coronary heart disease,<sup><xref ref-type="bibr" rid="bibr14-0300060513487625">14</xref>,<xref ref-type="bibr" rid="bibr46-0300060513487625">46</xref></sup> left ventricular hypertrophy<sup><xref ref-type="bibr" rid="bibr47-0300060513487625">47</xref></sup> and intracerebral haemorrhage.<sup><xref ref-type="bibr" rid="bibr15-0300060513487625">15</xref><xref ref-type="bibr" rid="bibr16-0300060513487625"/><xref ref-type="bibr" rid="bibr17-0300060513487625"/><xref ref-type="bibr" rid="bibr18-0300060513487625"/><xref ref-type="bibr" rid="bibr19-0300060513487625"/>–<xref ref-type="bibr" rid="bibr20-0300060513487625">20</xref></sup></p>
<p>In conclusion, data from the present study suggest that the <italic>ACE</italic> DD genotype may be a protective factor against IA in a Chinese population. A larger, multicentre study, which is statistically powered to detect differences in the risk of IA between different <italic>ACE</italic> genotypes, is required in order to confirm the present results.</p>
</sec>
</body>
<back>
<sec id="sec8-0300060513487625"><title>Declaration of conflicting interest</title>
<p>The authors declare that there are no conflicts of interest.</p>
</sec>
<sec id="sec9-0300060513487625"><title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China General Program (No.30872673 to C.Y.) and Youth Project (No. 30801185 to Y.L.).</p>
</sec>
<ref-list><title>References</title>
<ref id="bibr1-0300060513487625"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Ge</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Polymorphism rs4934 of SERPINA3 and sporadic intracranial aneurysms in the Chinese population</article-title>. <source>Cerebrovasc Dis</source> <year>2010</year>; <volume>29</volume>: <fpage>68</fpage>–<lpage>72</lpage>.</citation></ref>
<ref id="bibr2-0300060513487625"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rinkel</surname><given-names>GJ</given-names></name><name><surname>Djibuti</surname><given-names>M</given-names></name><name><surname>Algra</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Prevalence and risk of rupture of intracranial aneurysms: a systematic review</article-title>. <source>Stroke</source> <year>1998</year>; <volume>29</volume>: <fpage>251</fpage>–<lpage>256</lpage>.</citation></ref>
<ref id="bibr3-0300060513487625"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inagawa</surname><given-names>T</given-names></name></person-group>. <article-title>Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980–1989 and 1990–1998</article-title>. <source>Stroke</source> <year>2001</year>; <volume>32</volume>: <fpage>1499</fpage>–<lpage>1507</lpage>.</citation></ref>
<ref id="bibr4-0300060513487625"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></name><name><surname>Nelson</surname><given-names>LM</given-names></name><name><surname>Koepsell</surname><given-names>TD</given-names></name><etal/></person-group>. <article-title>Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington</article-title>. <source>Neurology</source> <year>1993</year>; <volume>43</volume>: <fpage>712</fpage>–<lpage>718</lpage>.</citation></ref>
<ref id="bibr5-0300060513487625"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hashikata</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Confirmation of an association of single-nucleotide polymorphism rs1333040 on 9p21 with familial and sporadic intracranial aneurysms in Japanese patients</article-title>. <source>Stroke</source> <year>2010</year>; <volume>41</volume>: <fpage>1138</fpage>–<lpage>1144</lpage>.</citation></ref>
<ref id="bibr6-0300060513487625"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>ZQ</given-names></name><name><surname>Wang</surname><given-names>QH</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Outcomes of endovascular coiling versus surgical clipping in the treatment of ruptured intracranial aneurysms</article-title>. <source>J Int Med Res</source> <year>2012</year>; <volume>40</volume>: <fpage>2145</fpage>–<lpage>2151</lpage>.</citation></ref>
<ref id="bibr7-0300060513487625"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Broderick</surname><given-names>JP</given-names></name><name><surname>Viscoli</surname><given-names>CM</given-names></name><name><surname>Brott</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable</article-title>. <source>Stroke</source> <year>2003</year>; <volume>34</volume>: <fpage>1375</fpage>–<lpage>1381</lpage>.</citation></ref>
<ref id="bibr8-0300060513487625"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ruigrok</surname><given-names>YM</given-names></name><name><surname>Rinkel</surname><given-names>GJ</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name></person-group>. <article-title>Genetics of intracranial aneurysms</article-title>. <source>Lancet Neurol</source> <year>2005</year>; <volume>4</volume>: <fpage>179</fpage>–<lpage>189</lpage>.</citation></ref>
<ref id="bibr9-0300060513487625"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nahed</surname><given-names>BV</given-names></name><name><surname>Bydon</surname><given-names>M</given-names></name><name><surname>Ozturk</surname><given-names>AK</given-names></name><etal/></person-group>. <article-title>Genetics of intracranial aneurysms</article-title>. <source>Neurosurgery</source> <year>2007</year>; <volume>60</volume>: <fpage>213</fpage>–<lpage>225</lpage>.</citation></ref>
<ref id="bibr10-0300060513487625"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skeggs</surname><given-names>LT</given-names></name><name><surname>Dorer</surname><given-names>FE</given-names></name><name><surname>Kahn</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>The biochemistry of the renin-angiotensin system and its role in hypertension</article-title>. <source>Am J Med</source> <year>1976</year>; <volume>60</volume>: <fpage>737</fpage>–<lpage>748</lpage>.</citation></ref>
<ref id="bibr11-0300060513487625"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rigat</surname><given-names>B</given-names></name><name><surname>Hubert</surname><given-names>C</given-names></name><name><surname>Alhenc-Gelas</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels</article-title>. <source>J Clin Invest</source> <year>1990</year>; <volume>86</volume>: <fpage>1343</fpage>–<lpage>1346</lpage>.</citation></ref>
<ref id="bibr12-0300060513487625"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiret</surname><given-names>L</given-names></name><name><surname>Rigat</surname><given-names>B</given-names></name><name><surname>Visvikis</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels</article-title>. <source>Am J Hum Genet</source> <year>1992</year>; <volume>51</volume>: <fpage>197</fpage>–<lpage>205</lpage>.</citation></ref>
<ref id="bibr13-0300060513487625"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Angiotensin-converting enzyme insertion/deletion polymorphism contributes to ischemic stroke risk: a meta-analysis of 50 case-control studies</article-title>. <source>PLoS One</source> <year>2012</year>; <volume>7</volume>: <fpage>e46495</fpage>–<lpage>e46495</lpage>.</citation></ref>
<ref id="bibr14-0300060513487625"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Xi</surname><given-names>B</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Meta-analysis of the association between the insertion/deletion polymorphism in ACE gene and coronary heart disease among the Chinese population</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2012</year>; <volume>13</volume>: <fpage>296</fpage>–<lpage>304</lpage>.</citation></ref>
<ref id="bibr15-0300060513487625"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Misra</surname><given-names>UK</given-names></name><name><surname>Kalita</surname><given-names>J</given-names></name><name><surname>Somarajan</surname><given-names>BI</given-names></name><etal/></person-group>. <article-title>Do ACE (rs4646994) and αADDUCIN (rs4961) gene polymorphisms predict the recurrence of hypertensive intracerebral hemorrhage?</article-title> <source>Neurol Sci</source> <year>2012</year>; <volume>33</volume>: <fpage>1071</fpage>–<lpage>1077</lpage>.</citation></ref>
<ref id="bibr16-0300060513487625"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Staalso</surname><given-names>JM</given-names></name><name><surname>Nielsen</surname><given-names>M</given-names></name><name><surname>Edsen</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Common variants of the ACE gene and aneurysmal subarachnoid hemorrhage in a Danish population: a case-control study</article-title>. <source>J Neurosurg Anesthesiol</source> <year>2011</year>; <volume>23</volume>: <fpage>304</fpage>–<lpage>309</lpage>.</citation></ref>
<ref id="bibr17-0300060513487625"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalita</surname><given-names>J</given-names></name><name><surname>Misra</surname><given-names>UK</given-names></name><name><surname>Bindu</surname><given-names>IS</given-names></name><etal/></person-group>. <article-title>Angiotensin-converting enzyme (rs4646994) and αADDUCIN (rs4961) gene polymorphisms' study in primary spontaneous intracerebral hemorrhage</article-title>. <source>Neurol India</source> <year>2011</year>; <volume>59</volume>: <fpage>41</fpage>–<lpage>46</lpage>.</citation></ref>
<ref id="bibr18-0300060513487625"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CM</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Wu</surname><given-names>YR</given-names></name><etal/></person-group>. <article-title>Angiotensin-converting enzyme polymorphisms and risk of spontaneous deep intracranial hemorrhage in Taiwan</article-title>. <source>Eur J Neurol</source> <year>2008</year>; <volume>15</volume>: <fpage>1206</fpage>–<lpage>1211</lpage>.</citation></ref>
<ref id="bibr19-0300060513487625"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slowik</surname><given-names>A</given-names></name><name><surname>Turaj</surname><given-names>W</given-names></name><name><surname>Dziedzic</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>DD genotype of ACE gene is a risk factor for intracerebral hemorrhage</article-title>. <source>Neurology</source> <year>2004</year>; <volume>63</volume>: <fpage>359</fpage>–<lpage>361</lpage>.</citation></ref>
<ref id="bibr20-0300060513487625"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slowik</surname><given-names>A</given-names></name><name><surname>Borratynska</surname><given-names>A</given-names></name><name><surname>Pera</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm</article-title>. <source>Stroke</source> <year>2004</year>; <volume>35</volume>: <fpage>1594</fpage>–<lpage>1597</lpage>.</citation></ref>
<ref id="bibr21-0300060513487625"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McColgan</surname><given-names>P</given-names></name><name><surname>Thant</surname><given-names>KZ</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name></person-group>. <article-title>The genetics of sporadic ruptured and unruptured intracranial aneurysms: a genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20,000 individuals</article-title>. <source>J Neurosurg</source> <year>2010</year>; <volume>112</volume>: <fpage>714</fpage>–<lpage>721</lpage>.</citation></ref>
<ref id="bibr22-0300060513487625"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pannu</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Seaman</surname><given-names>CR</given-names></name><etal/></person-group>. <article-title>Lack of an association between the angiotensin-converting enzyme insertion/deletion polymorphism and intracranial aneurysms in a Caucasian population in the United States</article-title>. <source>J Neurosurg</source> <year>2005</year>; <volume>103</volume>: <fpage>92</fpage>–<lpage>96</lpage>.</citation></ref>
<ref id="bibr23-0300060513487625"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keramatipour</surname><given-names>M</given-names></name><name><surname>McConnell</surname><given-names>RS</given-names></name><name><surname>Kirkpatrick</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>The ACE I allele is associated with increased risk for ruptured intracranial aneurysms</article-title>. <source>J Med Genet</source> <year>2000</year>; <volume>37</volume>: <fpage>498</fpage>–<lpage>500</lpage>.</citation></ref>
<ref id="bibr24-0300060513487625"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takenaka</surname><given-names>K</given-names></name><name><surname>Yamakawa</surname><given-names>H</given-names></name><name><surname>Sakai</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Angiotensin I-converting enzyme gene polymorphism in intracranial saccular aneurysm individuals</article-title>. <source>Neurol Res</source> <year>1998</year>; <volume>20</volume>: <fpage>607</fpage>–<lpage>611</lpage>.</citation></ref>
<ref id="bibr25-0300060513487625"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>C</given-names></name><name><surname>Kistler</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>J</given-names></name></person-group>. <article-title>Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning</article-title>. <source>Neurosurgery</source> <year>1980</year>; <volume>6</volume>: <fpage>1</fpage>–<lpage>9</lpage>.</citation></ref>
<ref id="bibr26-0300060513487625"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>The interleukin-6-572G/C gene polymorphism and the risk of intracranial aneurysms in a Chinese population</article-title>. <source>Genet Test Mol Biomarkers</source> <year>2012</year>; <volume>16</volume>: <fpage>822</fpage>–<lpage>826</lpage>.</citation></ref>
<ref id="bibr27-0300060513487625"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Tu</surname><given-names>Y</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Association of interleukin-6-572G/C gene polymorphisms in the Cantonese population with intracranial aneurysms</article-title>. <source>J Neurol Sci</source> <year>2011</year>; <volume>306</volume>: <fpage>94</fpage>–<lpage>97</lpage>.</citation></ref>
<ref id="bibr28-0300060513487625"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name></person-group>. <article-title>The interleukin-6 gene -572G &gt; C promoter polymorphism is related to intracranial aneurysms in Chinese Han nationality</article-title>. <source>Neurosci Lett</source> <year>2008</year>; <volume>440</volume>: <fpage>1</fpage>–<lpage>3</lpage>.</citation></ref>
<ref id="bibr29-0300060513487625"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takenaka</surname><given-names>K</given-names></name><name><surname>Sakai</surname><given-names>H</given-names></name><name><surname>Yamakawa</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Polymorphism of the endoglin gene in patients with intracranial saccular aneurysms</article-title>. <source>J Neurosurg</source> <year>1999</year>; <volume>90</volume>: <fpage>935</fpage>–<lpage>938</lpage>.</citation></ref>
<ref id="bibr30-0300060513487625"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>LJ</given-names></name><name><surname>Pan</surname><given-names>XM</given-names></name><name><surname>Sima</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Interactions of interleukin-12A and interleukin-12B polymorphisms on the risk of intracranial aneurysm</article-title>. <source>Mol Biol Rep</source> <year>2012</year>; <volume>39</volume>: <fpage>11217</fpage>–<lpage>11223</lpage>.</citation></ref>
<ref id="bibr31-0300060513487625"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joo</surname><given-names>SP</given-names></name><name><surname>Kim</surname><given-names>TS</given-names></name><name><surname>Lee</surname><given-names>IK</given-names></name><etal/></person-group>. <article-title>The role of collagen type I alpha2 polymorphisms: intracranial aneurysms in Koreans</article-title>. <source>Surg Neurol</source> <year>2009</year>; <volume>72</volume>: <fpage>48</fpage>–<lpage>53</lpage>.</citation></ref>
<ref id="bibr32-0300060513487625"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Ge</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Polymorphism rs42524 of COL1A2 and sporadic intracranial aneurysms in the Chinese population</article-title>. <source>J Neurosurg</source> <year>2008</year>; <volume>109</volume>: <fpage>1060</fpage>–<lpage>1064</lpage>.</citation></ref>
<ref id="bibr33-0300060513487625"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sima</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Interactions of miR-34b/c and TP53 polymorphisms on the risk of intracranial aneurysm</article-title>. <source>Clin Dev Immunol</source> <year>2012</year>; <volume>2012</volume>: <fpage>567586</fpage>–<lpage>567586</lpage>.</citation></ref>
<ref id="bibr34-0300060513487625"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semmler</surname><given-names>A</given-names></name><name><surname>Linnebank</surname><given-names>M</given-names></name><name><surname>Krex</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Polymorphisms of homocysteine metabolism are associated with intracranial aneurysms</article-title>. <source>Cerebrovasc Dis</source> <year>2008</year>; <volume>26</volume>: <fpage>425</fpage>–<lpage>429</lpage>.</citation></ref>
<ref id="bibr35-0300060513487625"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khurana</surname><given-names>VG</given-names></name><name><surname>Sohni</surname><given-names>YR</given-names></name><name><surname>Mangrum</surname><given-names>WI</given-names></name><etal/></person-group>. <article-title>Endothelial nitric oxide synthase T-786C single nucleotide polymorphism: a putative genetic marker differentiating small versus large ruptured intracranial aneurysms</article-title>. <source>Stroke</source> <year>2003</year>; <volume>34</volume>: <fpage>2555</fpage>–<lpage>2559</lpage>.</citation></ref>
<ref id="bibr36-0300060513487625"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TG</given-names></name><name><surname>Kim</surname><given-names>NK</given-names></name><name><surname>Baek</surname><given-names>MJ</given-names></name><etal/></person-group>. <article-title>The relationships between endothelial nitric oxide synthase polymorphisms and the formation of intracranial aneurysms in the Korean population</article-title>. <source>Neurosurg Focus</source> <year>2011</year>; <volume>30</volume>: <fpage>E23</fpage>–<lpage>E23</lpage>.</citation></ref>
<ref id="bibr37-0300060513487625"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krischek</surname><given-names>B</given-names></name><name><surname>Kasuya</surname><given-names>H</given-names></name><name><surname>Akagawa</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Using endothelial nitric oxide synthase gene polymorphisms to identify intracranial aneurysms more prone to rupture in Japanese patients</article-title>. <source>J Neurosurg</source> <year>2006</year>; <volume>105</volume>: <fpage>717</fpage>–<lpage>722</lpage>.</citation></ref>
<ref id="bibr38-0300060513487625"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pannu</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>DH</given-names></name><name><surname>Guo</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms</article-title>. <source>J Neurosurg</source> <year>2006</year>; <volume>105</volume>: <fpage>418</fpage>–<lpage>423</lpage>.</citation></ref>
<ref id="bibr39-0300060513487625"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>DG</given-names></name><name><surname>Kassam</surname><given-names>A</given-names></name><name><surname>St Jean</surname><given-names>PL</given-names></name><etal/></person-group>. <article-title>Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm</article-title>. <source>Stroke</source> <year>1999</year>; <volume>30</volume>: <fpage>2612</fpage>–<lpage>2616</lpage>.</citation></ref>
<ref id="bibr40-0300060513487625"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinsheimer</surname><given-names>S</given-names></name><name><surname>Goddard</surname><given-names>KA</given-names></name><name><surname>Parrado</surname><given-names>AR</given-names></name><etal/></person-group>. <article-title>Association of kallikrein gene polymorphisms with intracranial aneurysms</article-title>. <source>Stroke</source> <year>2007</year>; <volume>38</volume>: <fpage>2670</fpage>–<lpage>2676</lpage>.</citation></ref>
<ref id="bibr41-0300060513487625"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nawaz</surname><given-names>SK</given-names></name><name><surname>Hasnain</surname><given-names>S</given-names></name></person-group>. <article-title>Effect of ACE polymorphisms on the association between noise and hypertension in a Pakistani population</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2011</year>; <volume>12</volume>: <fpage>516</fpage>–<lpage>520</lpage>.</citation></ref>
<ref id="bibr42-0300060513487625"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramachandran</surname><given-names>V</given-names></name><name><surname>Ismail</surname><given-names>P</given-names></name><name><surname>Stanslas</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2008</year>; <volume>9</volume>: <fpage>208</fpage>–<lpage>214</lpage>.</citation></ref>
<ref id="bibr43-0300060513487625"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jimenez</surname><given-names>PM</given-names></name><name><surname>Conde</surname><given-names>C</given-names></name><name><surname>Casanegra</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Association of ACE genotype and predominantly diastolic hypertension: a preliminary study</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2007</year>; <volume>8</volume>: <fpage>42</fpage>–<lpage>44</lpage>.</citation></ref>
<ref id="bibr44-0300060513487625"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>WT</given-names></name><name><surname>Raynolds</surname><given-names>MV</given-names></name><name><surname>Badesch</surname><given-names>DB</given-names></name><etal/></person-group>. <article-title>Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics</article-title>. <source>J Renin Angiotensin Aldosterone Syst</source> <year>2003</year>; <volume>4</volume>: <fpage>27</fpage>–<lpage>30</lpage>.</citation></ref>
<ref id="bibr45-0300060513487625"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Angiotensin-converting enzyme I/D polymorphism and the risk of thoracic aortic dissection in Chinese Han population</article-title>. <source>Mol Biol Rep</source> <year>2013</year>; <volume>40</volume>: <fpage>1249</fpage>–<lpage>1254</lpage>.</citation></ref>
<ref id="bibr46-0300060513487625"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaisi-Raygani</surname><given-names>A</given-names></name><name><surname>Rahimi</surname><given-names>Z</given-names></name><name><surname>Tavilani</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Synergism between paraoxonase Arg 192 and the angiotensin converting enzyme D allele is associated with severity of coronary artery disease</article-title>. <source>Mol Biol Rep</source> <year>2012</year>; <volume>39</volume>: <fpage>2723</fpage>–<lpage>2731</lpage>.</citation></ref>
<ref id="bibr47-0300060513487625"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Jia</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis</article-title>. <source>Mol Biol Rep</source> <year>2012</year>; <volume>39</volume>: <fpage>10063</fpage>–<lpage>10075</lpage>.</citation></ref>
</ref-list>
</back>
</article>